Why the study?
Ascending aortic pseudoaneurysms carry high surgical morbidity, but there are no FDA-approved devices for endovascular repair of zone 0 pathology.
Does endovascular repair using the GORE TAG Thoracic Branch Endoprosthesis Aortic Extender successfully exclude ascending aortic pseudoaneurysms in high-risk surgical candidates?
Does endovascular repair using the GORE TAG Thoracic Branch Endoprosthesis Aortic Extender successfully exclude ascending aortic pseudoaneurysms in high-risk surgical candidates?
Answers are grounded in this paper and cite their sources.
The GORE TAG Thoracic Branch Endoprosthesis Aortic Extender can be successfully used off-label for endovascular repair of ascending aortic pseudoaneurysms in high-risk surgical candidates.
Ascending aortic pseudoaneurysms (AAPs) are a rare but morbid complication after cardiac surgery. Although the mainstay of AAP treatment is open surgery, endovascular repair can be considered for high-risk surgical candidates with suitable anatomy. With no US Food and Drug Administration-approved devices for the treatment of zone 0 pathology, endovascular repair of AAP is being performed with off-label use of available devices. Here we present two cases of successful AAP exclusion using the GORE TAG Thoracic Branch Endoprosthesis Aortic Extender.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: